- Previous Close
0.3590 - Open
0.3310 - Bid 0.3310 x --
- Ask 0.3400 x --
- Day's Range
0.3310 - 0.3400 - 52 Week Range
0.2700 - 1.1400 - Volume
24,305 - Avg. Volume
295,590 - Market Cap (intraday)
79.84M - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.50
Biosergen AB, a biotech company, develops antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of fungal infections. The company was founded in 2004 and is based in Solna, Sweden.
biosergen.netRecent News: BIOSGN.ST
View MorePerformance Overview: BIOSGN.ST
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIOSGN.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIOSGN.ST
View MoreValuation Measures
Market Cap
84.30M
Enterprise Value
33.69M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.72
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-38.69%
Return on Equity (ttm)
-73.32%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-18.79M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
50.61M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-10.04M